X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA member companies share how they are improving clinical trial diversity

By Dr. Freda Lewis-Hall  |    April 14, 2021
As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial...   Read More

Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen

By Courtney Christian  |    January 28, 2021
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.   Read More

Paper finds gaps in health data are a barrier to health equity

By Emily Donaldson  |    January 11, 2021
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to...   Read More

New research shows hotspots of inequity relate to increased COVID-19 hospitalizations

By Jackie McRae  |    January 8, 2021
As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this...   Read More

Increasing diversity at investigator sites could increase minority participation in clinical trials

By Guest Contributor  |    December 17, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

New report highlights biopharmaceutical industry’s commitment to D&I

By Abigail Lore  |    December 17, 2020
Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the...   Read More

Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US

By Stephen J. Ubl  |    December 16, 2020
This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections....   Read More

PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence

By Jackie McRae  |    November 24, 2020
Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – ...   Read More

Committing to diversity, equity and inclusion: A call to action for clinical trials

By Guest Contributor  |    November 19, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Just released: PhRMA members’ new clinical trial diversity principles

By Richard Moscicki, M.D.  |    November 18, 2020
Yesterday, PhRMA published first ever industry-wide principles on clinical trial diversity, a new chapter in the already existing “Principles on Conduct of Clinical Trials & Communication of...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates